Luciane Senra de Souza Braga

Luciane Senra de Souza Braga

Auto-generated profile, based on publicly available information

Luciane Senra de Souza Braga

Universidade Federal de Juiz de Fora, Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Brazilian Journal of Nephrology
Verified
Journal Article
Open access
PDF file
LSLuciana Senra de Souza Sodré
Luciana Senra de Souza Sodré
RHRosália Maria Nunes Henriques Huaira
Rosália Maria Nunes Henriques Huaira
FCFernando Antonio Basile Colugnati
Fernando Antonio Basile Colugnati
MCMoises Carminatti
Moises Carminatti
LBLuciane Senra de Souza Braga
Luciane Senra de Souza Braga
NFNatália M.S. Fernandes
Natália M.S. Fernandes
Introduction: Fabry disease is a chronic, progressive, and multi-system hereditary condition, related to an Xq22 mutation in X chromosome, which results in deficiency of alpha-galactosidase enzyme, hence reduced capacity of globotriaosylceramide degradation. Objectives: to evaluate the prevalence of Fabry disease (FD) mutations, as well as its signs and symptoms, among relatives of chronic kidney disease (CKD) patients diagnosed with FD during a previously conducted study, named “Clinical and epidemiological analysis of Fabry disease in dialysis centers in Brazil”. Methods: a cross-sectional study was carried out, and data was collected by interviewing the relatives of patients enrolled in the Brazil Fabry Kidney Project and blood tests for both Gb3 dosage and genetic testing. Results: Among 1214 interviewed relatives, 115 (9.47%) were diagnosed with FD, with a predominance of women (66.10%). The most prevalent comorbidities were rheumatologic conditions and systemic hypertension (1.7% each), followed by heart, neurological, cerebrovascular diseases, and depression in 0.9% of individuals. Intolerance to physical exercise and tiredness were the most observed symptoms (1.7%), followed by periodic fever, intolerance to heat or cold, diffuse pain, burn sensation or numbness in hands and feet, reduced or absent sweating, as well as abdominal pain after meals in 0.9%. Conclusion: We found a prevalence of Fabry disease in 9.47% of relatives of CKD patients with this condition, remarkably with a 66.1% predominance of women, which contrasts with previous reports. The screening of family members of FD patients is important, since it can lead to early diagnosis and treatment, thus allowing better quality of life and improved clinical outcomes for these individuals.

1 June 2026 in Brazilian Journal of Nephrology
Verified
Journal Article
Open access
CJCelso Souza de Moraes- Júnior
Celso Souza de Moraes- Júnior
NONatalia Orihuela
Natalia Orihuela
NFNatália M.S. Fernandes
Natália M.S. Fernandes
LCLaura Cortés-Sanabria
Laura Cortés-Sanabria
LBLuciane Senra de Souza Braga
Luciane Senra de Souza Braga
JDJosè Divino-Filho
Josè Divino-Filho
Introduction: The main tools for making clinical decisions based on efficient use of resources are economic evaluation studies that allow the assessment of both the costs and benefits of different therapeutics, with appropriate guidelines for preparing reports. This study aimed to develop a checklist of consumable cost elements to be considered in estimates for micro-costing studies in peritoneal dialysis (PD). Methods: Four stages were conducted, followed by data analysis and interpretation. Three stages were carried out to develop the direct cost elements questionnaire: 1st — designing the first version of the checklist; 2nd — evaluating and expanding it using the Delphi method; 3rd — conducting two expert panels; and 4th — applying the questionnaire to professionals from 18 Latin American countries. Inclusion criteria: professionals with at least one year of clinical and/or administrative experience in PD. A discrete probability distribution adjustment was performed. Distribution lots were considered according to the category of cost elements for each country. The maximum likelihood estimation method was applied, and the statistical classification of the adjustments was assessed using the Akaike Information Criterion. Results: A total of 596 questionnaires, comprising seven dimensions and 41 elements, were validated. From the results of each batch, it was possible to segment the elements into three choice options, with the probability of evaluating an element as very important, thus allowing for the classification of the cost elements. Conclusion: The checklist favors more equitable economic dimensioning in comparative studies, making it possible to compare economic values in PD across countries, while considering the appropriate cost elements.

1 June 2026 in Brazilian Journal of Nephrology
Verified
Journal Article
Open access
CJCelso Souza de Moraes- Júnior
Celso Souza de Moraes- Júnior
NONatalia Orihuela
Natalia Orihuela
NFNatália M.S. Fernandes
Natália M.S. Fernandes
LCLaura Cortés-Sanabria
Laura Cortés-Sanabria
LBLuciane Senra de Souza Braga
Luciane Senra de Souza Braga
JDJosè Divino-Filho
Josè Divino-Filho
Resumo Introdução: As principais ferramentas para a tomada de decisões clínicas baseadas no uso eficiente de recursos são estudos de avaliação econômica que permitem avaliar tanto os custos quanto os benefícios de diferentes terapêuticas, com diretrizes adequadas para a elaboração de relatórios. Este estudo teve como objetivo desenvolver um checklist de elementos de custo de consumo a serem considerados em estimativas para estudos de microcusteio em diálise peritoneal (DP). Métodos: Foram trabalhadas quatro etapas, seguidas de análise e interpretação dos dados. Três etapas foram realizadas para o desenvolvimento do questionário de elementos de custo direto: 1ª – elaboração da primeira versão do checklist; 2ª – avaliação e expansão com a aplicação do método Delphi; 3ª – realização de dois painéis de especialistas; e 4ª – aplicação do questionário a profissionais de 18 países latino-americanos. Critérios de inclusão: profissionais com pelo menos um ano de experiência clínica e/ou administrativa em DP. Foi realizado um ajuste por distribuição de probabilidade discreta. Foram considerados lotes de distribuição por categoria de elementos de custo por país. Aplicou-se o método de estimação por máxima verossimilhança, e a classificação estatística dos ajustes foi estimada utilizando o Critério de Informação de Akaike. Resultados: Foram validados 596 questionários, com sete dimensões e 41 elementos. A partir dos resultados de cada lote, foi possível segmentar os elementos em três opções de escolha, com probabilidade de avaliar um elemento como muito importante, classificando assim os elementos de custo. Conclusão: O checklist favorece um dimensionamento econômico mais equitativo em estudos comparativos, possibilitando a comparação de valores econômicos em DP entre países, considerando os elementos de custo adequados.